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with infections of mucosal epithelia 
and can be grouped into “low-risk” 
and “high-risk” types, depending on 
the relative propensity of the neoplasms 
that these viruses cause to undergo 
malignant progression. Low-risk HPV 
infections cause mostly benign genital 
warts (condyloma acuminata), whereas 
high-risk HPV infections can give rise 
to potentially premalignant squamous 
intraepithelial neoplasias. Although 
progression of such lesions is generally 
a slow and infrequent event, >99% of 
human cervical carcinomas are caused 
by high-risk HPV infections. In addition, 
a significant percentage of other ano-
genital tract cancers, as well as approxi-
mately 20% of human oral carcinomas, 
are associated with high-risk HPV infec-
tions. The recently introduced prophy-
lactic HPV vaccine Gardasil is used for 
protection from new infections with the 
two most common high-risk (HPV16 
and HPV18) and low-risk (HPV6 and 
HPV11) HPV types. Given the relative 
abundance of specific HPV types, these 
vaccines have the potential to prevent 
up to 70% of cervical cancers, as well 
as a similar percentage of genital warts.
High-risk α-HPVs also have a much 
higher transforming potential than low-
risk HPVs in vitro. These viruses express 
three proteins—E5, E6, and E7—that 
have transforming activities in cell- 
and or animal-based model systems. 
Of these, only E6 and E7 are regularly 
expressed in cervical cancers, and their 
persistent expression is necessary for 
the maintenance of the transformed 
phenotype.
How may β-genus HPVs contribute to 
nonmelanoma skin cancer development?
β-HPVs comprise a similarly large 
group of HPVs. The most extensively 
studied are HPV5 and HPV8. These 
are associated with EV, a rare skin 
disease that can eventually progress 
to squamous cell carcinoma, particu-
larly in sun-exposed areas of the body. 
Infection with HPV5 or HPV8 is not 
sufficient for EV development, and indi-
viduals are genetically predisposed to 
developing this condition. It is an auto-
somal recessive, genetically heteroge-
neous disease, and loci on the X chro-
mosome—17q25 (EV1) and 2p21-p24 
(EV2)—have been implicated. Two 
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The Human Papillomavirus Type 8 e2 
Gene encodes a Transforming Activity 
Sufficient for Skin Tumor formation 
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Infections with β-genus human papillomaviruses (HPVs) have been associated 
with nonmelanoma skin cancers, particularly in immunocompromised patients 
and individuals with a rare genetic disease, epidermodysplasia verruciformis 
(eV). Using a transgenic mouse model, Herbert Pfister’s group determined that 
expression of the HPV8 e2 gene results in skin cancer development and that this 
process is greatly accelerated by UV irradiation (Pfefferle et al., 2008, this issue).
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HPVs encompass more than 100 geno-
types. They consist of small 8,000-bp, 
double-strand circular DNA genomes 
packaged into non-enveloped, icosahe-
dral, ~55-nm particles. The nonstructural 
early (E) genes encode proteins that are 
necessary for viral replication, whereas 
the late (L) genes, L1 and L2, encode 
the major and minor capsid proteins, 
respectively. The viral life cycle is tightly 
coupled to the differentiation process of 
the infected squamous epithelium; the 
initial infection targets the basal epithe-
lial cells, which make up the major layer 
in the skin that actively proliferates. 
High-level viral genome replication, 
expression of late genes, and produc-
tion of viral progeny, however, are 
restricted to the suprabasal, terminally 
differentiated layers of the skin. Hence, 
HPVs encode activities to reprogram 
the infected cell by uncoupling growth 
arrest and differentiation programs, and 
this is clinically manifested by the for-
mation of generally benign epithelial 
hyperplasias, or warts.
HPVs are classified into several phylo-
genetic groups. Of these, the α-genus 
HPVs have been studied most exten-
sively. α-genus HPVs are associated 
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have accumulated genomic altera-
tions to survive and form the seeds of a 
tumor. Such a model is consistent with 
epidemiologic studies, as well as the 
original observations with EV patients 
that have demonstrated cooperation of 
HPV infection with UV exposure. As 
such, infection with certain β-genus 
HPVs would represent a cofactor for 
UV irradiation-induced skin carcino-
genesis (Jackson et al., 2000).
Another fruitful approach to gain 
insight into the transforming activities of 
HPV genes has been the development 
of mouse models. In the case of high-
risk α-genus HPVs, targeted expression 
of HPV16 E6/E7 oncogenes in the basal 
epithelium from a human keratin K14 
promoter can give rise to cervical cancer 
when the mice are persistently treated 
with low doses of estrogen (Arbeit et al., 
1994). A similar approach by Pfister’s 
group documented the emergence of 
skin tumors in transgenic mice in which 
the entire early region of HPV8 was 
expressed from the keratin K14 promoter 
without any co-carcinogen treatment. 
These results clearly documented the 
oncogenic potential of HPV8 (Schaper 
et al., 2005).
As pointed out by the authors, their 
previous tissue culture experiments 
suggested that HPV8 E2 expression 
may abrogate anoikis and contribute 
to anchorage-independent growth. 
In their current study, Pfister’s group 
reports that the HPV8 E2 protein indeed 
has potent transforming activities and is 
sufficient for development of skin can-
cers (Pfefferle et al., 2008, this issue). 
Most interestingly, development of skin 
tumors is greatly accelerated upon UV 
treatment that mimics sun exposure. 
All three carcinomas that developed in 
the HPV8 E2-transgenic mice displayed 
an unusually high proportion of spin-
dle-shaped cells similar to aggressive 
skin tumors from immunosuppressed 
organ-transplant recipients. Spindle 
cells are often a hallmark of epithelial-
to-mesenchymal transition, suggesting 
that HPV8 E2 expression may trigger 
this process.
These findings, of course, do not rule 
out the possibility that E6 and E7 may 
also contribute to skin cancer develop-
ment, because tumors took longer to 
develop in the HPV8 E2-transgenic mice 
This is based on the observation that, 
similarly to high-risk α-HPVs, HPV38 
E6/E7 expression results in life-span 
extension of primary human epithe-
lial cells and the HPV38 E7 protein has 
transforming activities in rodent fibro-
blasts (Caldeira et al., 2003). Moreover, 
HPV38 E6/E7 transgenic mice develop 
skin hyperplasias and are sensitized to 
chemical carcinogen-induced skin car-
cinogenesis (Dong et al., 2005).
transforming activities of β-genus HPVs
Surprisingly little is known about the 
transforming properties of the β-genus 
HPVs, most likely because of the 
absence of robust transformation assays 
in tissue culture systems. Because 
HPV5 and HPV8 do not contain a 
recognizable E5 open reading frame 
(ORF), most studies have focused on E6 
and E7. These proteins do not appear 
to target the p53 and pRB tumor sup-
pressors for degradation. An important 
mechanistic breakthrough was the find-
ing that, similarly to α-HPVs, β-HPV 
E6 proteins can associate with and 
induce the degradation of the proapop-
totic bcl2 family member bak. On the 
basis of these studies, it was suggested 
that β-HPV infections would blunt the 
apoptotic response to UV irradiation 
and allow UV-damaged cells that may 
candidate genes for EV1 on 17q25, 
EVER1 and EVER2, have been identi-
fied. It is likely that EV patients can-
not effectively control or clear β-genus 
HPV infections (reviewed by Orth, 
2006). The importance of immune sur-
veillances to control β-HPV-associated 
disease and cancer is supported by the 
finding that the incidence of β-genus 
HPV-associated squamous cell carci-
nomas is sharply increased in immuno-
compromised patients; HPV-associated 
skin cancers are a frequent complica-
tion in immunosuppressed organ-trans-
plant patients.
Nonetheless, the mechanistic con-
tributions of β-genus HPVs to devel-
opment of skin cancers have not been 
clearly established because β-HPV 
infections are very frequent in the gen-
eral population—it is conceivable that 
some β-HPVs constitute part of a rela-
tively innocuous “viral skin flora.” A 
major research effort in this field has 
therefore been directed toward inves-
tigating whether, similarly to α-HPVs, 
β-HPVs can be classified into low-risk 
and high-risk types. This would obvi-
ously be important for vaccine develop-
ment. In addition to HPV5 and HPV8, 
which are most frequently associated 
with EV, it has been suggested that 
HPV38 may be a high-risk HPV type. 
Figure 1. Potential mechanisms by which expression of the HPV8 e2 orF may contribute to skin 
tumor formation. The consensus pol III promoter sequences within the E2 ORF (Fuchs et al., 1986) 
are shown. The gray shading and the question mark indicate that there is no experimental evidence for 
expression of small RNAs in HPV8. The most conserved residues are highlighted in yellow. R, purine; Y, 
pyrimidine; N, any nucleotide. See text for details.
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and thereby modulate keratinocyte dif-
ferentiation. Hence, it is possible that 
skin cancer formation by HPV8 E2 
expression may be a consequence of 
E2’s transcriptional activities.
The authors also speculate that the 
HPV8 E2 protein may contribute to 
skin cancer formation through func-
tional modulation of other potential E2 
cellular target proteins, including the 
p53 tumor suppressor and the DNA 
damage-response proteins TopBP-1 
and PARP, each of which has well-
documented activities in the UV DNA 
damage response.
E2 proteins associate with mitotic 
chromosomes to mediate viral genome 
partitioning during mitosis. β-genus 
HPV E2 proteins have been shown to 
uniquely associate with pericentro-
meric regions of mitotic chromosomes 
(Oliveira et al., 2006). Although the 
cellular proteins necessary for this 
association are not known, it is pos-
sible that ectopic HPV8 E2 expression 
might interfere with kinetochore func-
tion, which could in turn lead to mitot-
ic abnormalities and aneuploidization. 
Indeed, the tumors in the HPV8 E2 
transgenic mice exhibit mitotic abnor-
malities and nuclear atypia.
Last, but not least, when Pfister’s 
group originally cloned the HPV8 
genome more than 20 years ago, they 
noted that the E2 ORF harbors a poten-
tial RNA polymerase III (Pol III) promot-
er. Although they could not demonstrate 
the presence of Pol III-derived small 
RNAs at that time (Fuchs et al., 1986) 
and there is no evidence for small, 
noncoding RNAs with the α-genus 
HPV31 (Cai et al., 2006), it might be 
interesting to reconsider whether the 
HPV8 ORF has the capacity to encode 
small, noncoding RNAs, whether they 
are expressed in the transgenic animal 
model reported here, and whether the 
presence of the Pol II promoter is nec-
essary for the transforming potential of 
the HPV8 E2 ORF (Figure 1).
than in the HPV8-early region-transgenic 
mice. Moreover, HPV8 E7 causes inva-
sion of human keratinocytes into the 
dermis in an organotypic cell culture 
model (Akgul et al., 2005).
How may HPV8 e2 expression 
contribute to skin cancer formation?
The full-length HPV E2 proteins serve 
three known functions: transcriptional 
regulation, viral genome replication 
in complex with the E1 origin binding 
helicase, and acting as a platform for 
tethering the viral genome to mitotic 
chromosomes.
The full-length E2 protein binds to 
ACCN6GGT imperfect palindromes 
in the viral genome and can act as a 
transcriptional activator as well as a 
repressor. E2 expression in HPV-positive 
cervical carcinoma lines causes growth 
arrest, senescence, and apoptosis, but 
these effects are mediated mostly by 
reducing expression of the E6/E7 onco-
genes. It is conceivable, however, that 
there are cellular genes that are regulat-
ed by E2. Interestingly, ectopic BPV1 E2 
expression causes reduced expression 
of the cdc25A gene in cervical cancer 
cell lines, and the human cdc25A gene 
contains a consensus E2 binding site in 
the 5′ untranslated region. It is unclear, 
however, whether cdc25A is a direct 
transcriptional target of E2 or wheth-
er the observed reduction of cdc25A 
expression is due to E2F-mediated 
repression as a consequence of reduced 
E7 expression (Wu et al., 2000). As 
pointed out by Pfefferle et al., the HPV8 
E2 protein can associate with C/EBPβ 
and enhance its transcriptional activity 
|UVR accelerates carcinogenesis in HPV8 E2-transgenic mice.
